Imunon, Inc. — Director's Dealing 2021

Dec 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-12-14

Reporting Person: Kardaras Constantine John (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-14	Celsion Corporation Common Stock	A	10000	—	Acquired	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-14	Option to Purchase Celsion Corporation Common Stock	$0.63	A	35000	Acquired	2031-12-14	Celsion Corporation Common Stock (35000)	Direct

Footnotes

F1: Stock grant award which will vest on the first anniversary of hire date (December 6, 2022). Fair value of the stock award is $0.63 per share based on the closing price of Celsion Common Stock the award date.

F2: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant.

F3: Represents the per share fair value of the common stock based on the closing price of a share of Celsion Common Stock on the date of the award.